InsiderClue
Insiders · Profile

Semigran Marc

Chief Development Officer at Edgewise Therapeutics. Filing since 24 Dec 2024. CIK 0001691494

Company
Date
Role
Action
Shares
Amount
Of holding
EWTX Edgewise Therapeutics, Inc.
24 Dec 2024
Chief Development Officer
Sold on a plan
29,709
$881.92K
81.6%
1 decision on file.